137 related articles for article (PubMed ID: 24420781)
1. Absence of an association between Plasmodium falciparum infection and post-ivermectin Loa-related non-neurologic serious adverse events.
Fokom-Domgue J; Pion SD; Gounoue R; Akame J; Nguipdop-Djomo P; Twum-Danso NA; Thylefors B; Boussinesq M; Kamgno J
Am J Trop Med Hyg; 2014 Feb; 90(2):335-8. PubMed ID: 24420781
[TBL] [Abstract][Full Text] [Related]
2. Molecular Epidemiology of Blood-Borne Human Parasites in a Loa loa-, Mansonella perstans-, and Plasmodium falciparum-Endemic Region of Cameroon.
Drame PM; Montavon C; Pion SD; Kubofcik J; Fay MP; Nutman TB
Am J Trop Med Hyg; 2016 Jun; 94(6):1301-1308. PubMed ID: 27044568
[TBL] [Abstract][Full Text] [Related]
3. Familial Aggregation and Heritability of Loa loa Microfilaremia.
Eyebe S; Sabbagh A; Pion SD; Nana-Djeunga HC; Kamgno J; Boussinesq M; Chesnais CB
Clin Infect Dis; 2018 Feb; 66(5):751-757. PubMed ID: 29040446
[TBL] [Abstract][Full Text] [Related]
4. Characterising co-infections with Plasmodium spp., Mansonella perstans or Loa loa in asymptomatic children, adults and elderly people living on Bioko Island using nucleic acids extracted from malaria rapid diagnostic tests.
Yoboue CA; Hosch S; Donfack OT; Guirou EA; Nlavo BM; Ayekaba MO; Guerra C; Phiri WP; Garcia GA; Schindler T; Daubenberger CA
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0009798. PubMed ID: 35100277
[TBL] [Abstract][Full Text] [Related]
5. Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia.
Fobi G; Gardon J; Santiago M; Ngangue D; Gardon-Wendel N; Boussinesq M
Ophthalmic Epidemiol; 2000 Mar; 7(1):27-39. PubMed ID: 10652169
[TBL] [Abstract][Full Text] [Related]
6. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
[TBL] [Abstract][Full Text] [Related]
7. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
[TBL] [Abstract][Full Text] [Related]
8. Assessment of loiasis and outcomes of ivermectin masstreatment in Ijebu-North, Nigeria.
Hassan AA; Akinsanya B; Iyase N; Owagboriaye FO
Korean J Parasitol; 2011 Jun; 49(2):153-9. PubMed ID: 21738271
[TBL] [Abstract][Full Text] [Related]
9. Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events.
Kamgno J; Pion SD; Mackenzie CD; Thylefors B; Boussinesq M
Am J Trop Med Hyg; 2009 Dec; 81(6):1056-61. PubMed ID: 19996437
[TBL] [Abstract][Full Text] [Related]
10. Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.
Bennuru S; Pion SD; Kamgno J; Wanji S; Nutman TB
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3180. PubMed ID: 25232954
[TBL] [Abstract][Full Text] [Related]
11. Individual risk of post-ivermectin serious adverse events in subjects infected with
Chesnais CB; Pion SD; Boullé C; Gardon J; Gardon-Wendel N; Fokom-Domgue J; Kamgno J; Boussinesq M
EClinicalMedicine; 2020 Nov; 28():100582. PubMed ID: 33294807
[TBL] [Abstract][Full Text] [Related]
12. Projected Number of People With Onchocerciasis-Loiasis Coinfection in Africa, 1995 to 2025.
Vinkeles Melchers NVS; Coffeng LE; Boussinesq M; Pedrique B; Pion SDS; Tekle AH; Zouré HGM; Wanji S; Remme JH; Stolk WA
Clin Infect Dis; 2020 May; 70(11):2281-2289. PubMed ID: 31304961
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of capillary and venous blood samples in the detection of Loa loa and Mansonella perstans microfilaraemia using light microscopy.
Mischlinger J; Manego RZ; Mombo-Ngoma G; Ekoka Mbassi D; Hackbarth N; Ekoka Mbassi FA; Davi SD; Kreuzmair R; Veletzky L; Hergeth J; Ndoumba WN; Pitzinger P; Groger M; Matsiegui PB; Adegnika AA; Agnandji ST; Lell B; Ramharter M
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009623. PubMed ID: 34398886
[TBL] [Abstract][Full Text] [Related]
14. The relationship between microfilaraemic and amicrofilaraemic loiasis involving co-infection with Mansonella perstans and clinical symptoms in an exposed population from Gabon.
Bouyou Akotet MK; Owono-Medang M; Mawili-Mboumba DP; Moussavou-Boussougou MN; Nzenze Afène S; Kendjo E; Kombila M
J Helminthol; 2016 Jul; 90(4):469-75. PubMed ID: 26268068
[TBL] [Abstract][Full Text] [Related]
15. Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.
Pion DS; Gardon J; Kamgno J; Gardon-Wendel N; Chippaux JP; Boussinesq M
Parasitology; 2004 Nov; 129(Pt 5):613-26. PubMed ID: 15552406
[TBL] [Abstract][Full Text] [Related]
16. Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis.
Twum-Danso NA; Meredith SE
Trop Med Int Health; 2003 Sep; 8(9):820-31. PubMed ID: 12950668
[TBL] [Abstract][Full Text] [Related]
17. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
[TBL] [Abstract][Full Text] [Related]
18. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
[TBL] [Abstract][Full Text] [Related]
19. Loiasis is endemic in the Ndikinimeki Health District (Centre Region, Cameroon) but does not represent a hindrance to onchocerciasis elimination.
Sumo L; Ntonifor NH; Afor AR; Bopda J; Bamou Heumou R; Ondoua Nganjou GS; Nana Djeunga HC
Acta Trop; 2022 Jan; 225():106218. PubMed ID: 34755644
[TBL] [Abstract][Full Text] [Related]
20. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
